No record found


* Returns not adjusted for payouts
Company Profile
Highnoon Laboratories Limited was incorporated in Pakistan under the Companies Act, 2017. The Company is principally engaged in the manufacture, import, sale and marketing of pharmaceutical and allied consumer products.
Dr. Adeel Abbas Haideri | CEO |
Mr. Tausif Ahmad Khan | Chairman |
Ms. Mahnoor Ather | Company Secretary |
Corplink (Pvt) Ltd. Wings Arcade 1 K Commercial, Model Town, Lahore.
EY Ford Rhodes Chartered Accountants.
December
Equity Profile
Announcements
Date | Title | Document |
---|---|---|
May 2, 2023 | Transmission of Quarterly Report for the period ended 31 March 2023 | View PDF |
May 2, 2023 | Financial Results for the Quarter ended 31 March 2023 | View PDF |
Apr 7, 2023 | Transmission of Annual Report for the year ended 31 December 2022 | View PDF |
Feb 23, 2023 | Financial Results for the Year ended 31 December 2022 | View PDF |
Oct 27, 2022 | Financial Results for the Quarter Ended September 30,2022 | View PDF |
Aug 31, 2022 | Transmission of Quarterly Report for the period ended June 30,2022 | View PDF |
Aug 15, 2022 | Financial Results for the half year ended June 30,2022 | View PDF |
Apr 18, 2022 | Financial Results for the Quarter ended March 31,2022 | View PDF |
Mar 29, 2022 | Transmission of Annual Report for the year ended December 31,2021 | View PDF |
Mar 16, 2022 | Financial Results for the year ended December 31,2021 | View PDF |
Date | Title | Document |
---|---|---|
Apr 19, 2023 | Board Meeting | View |
Apr 7, 2023 | Publication of Notice of Annual General Meeting in Newspapers | View PDF |
Apr 7, 2023 | Notice of Annual General Meeting | View PDF |
Feb 16, 2023 | Board Meeting | View |
Dec 12, 2022 | Board Meeting Other Than Financial Results | View |
Oct 20, 2022 | Board Meeting | View PDF |
Aug 5, 2022 | Board Meeting | View PDF |
Apr 18, 2022 | Shareholders' Resolution at the 39th Annual General Meeting of the Company | View PDF |
Apr 11, 2022 | Board Meeting | View PDF |
Mar 28, 2022 | Notice of Annual General Meeting | View PDF |
Date | Title | Document |
---|---|---|
May 29, 2023 | Credit of Bonus Share Certificates | View |
May 15, 2023 | Dispatch of Final Dividend Warrants | View |
Apr 20, 2023 | Corporate Briefing Session | View PDF |
Apr 7, 2023 | Book Closure Dates | View PDF |
Mar 27, 2023 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Feb 23, 2023 | Appointment of Director | View |
Jan 20, 2023 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Jan 17, 2023 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Dec 19, 2022 | Resignation of Director | View |
Dec 12, 2022 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Dec 2, 2022 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Financials
All numbers in thousands (000's) except EPS
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Sales | 15,815,937 | 13,000,780 | 10,697,634 | 9,047,693 |
Profit after Taxation | 2,417,172 | 1,808,033 | 1,420,736 | 971,013 |
EPS | 57.71 | 43.17 | 41.04 | 28.05 |
Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | |
---|---|---|---|---|
Sales | 4,872,781 | 4,191,865 | 4,327,695 | 3,756,034 |
Profit after Taxation | 625,508 | 661,814 | 559,651 | 533,700 |
EPS | 14.93 | 15.80 | 13.36 | 12.74 |

Ratios
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Gross Profit Margin (%) | 50.77 | 49.35 | 47.87 | 46.00 |
Net Profit Margin (%) | 15.28 | 13.91 | 13.28 | 10.73 |
EPS Growth (%) | 33.68 | 5.19 | 46.31 | 21.59 |
PEG | 0.28 | 2.80 | 0.32 | 0.89 |
Payouts
Date | Financial Results | Details | Book Closure |
---|---|---|---|
February 23, 2023 2:48 PM | 31/12/2022(YR) | 10% (B) - 200%(F) (D) | 22/04/2023 - 29/04/2023 |
March 16, 2022 3:48 PM | 31/12/2021(YR) | 200% (D) - 10% (B) | 11/04/2022 - 18/04/2022 |
March 25, 2021 4:01 PM | 31/12/2020(YR) | 150%(F) (D) - 10% (B) | 26/04/2021 - 27/04/2021 |
March 31, 2020 3:12 PM | 31/12/2019(YR) | 130% (D) - 10% (B) | 05/05/2020 - 12/05/2020 |
March 29, 2019 4:20 PM | 31/12/2018(YR) | 130%(F) (D) - 10% (B) | 23/04/2019 - 29/04/2019 |
March 9, 2018 3:55 PM | 31/12/2017(YR) | 100% (D) - 12% (B) | 12/04/2018 - 23/04/2018 |
March 16, 2017 3:45 PM | 31/12/2016(YR) | 85% (D) - 12% (B) | 21/04/2017 - 27/04/2017 |
March 15, 2016 3:38 PM | 31/12/2015(YR) | 75% (D) - 12% (B) | 14/04/2016 - 22/04/2016 |
March 20, 2015 3:49 PM | 31/12/2014(YR) | 65% (D) - 12% (B) | 17/04/2015 - 27/04/2015 |
March 18, 2014 2:49 PM | 31/12/2013(YR) | 45% (D) | 15/04/2014 - 24/04/2014 |